The race to develop the next generation of medicines just got faster. At least, that is the bet Novo Nordisk...
Novo
Hims & Hers (HIMS) has taken a beating, with the stock down roughly 70% from its $70 peak and now...
Global trade, energy transition, financial regulation, multinational corporations, and macroeconomic trends.
